Biomarkers.

Background: With global dementia prevalence estimated to reach 139 million by 2050, early detection of dementia-causing diseases is crucial for promoting preventative interventions. Wearable technologies have the potential to detect early signs; however, they need to be acceptable amongst users. We explored user's perspectives on the acceptability of wearable devices.

Biomarkers.

Background: Outdoor air pollution is a global issue which poses a significant health risk. Modern neuroimaging techniques have revealed the detrimental impact of air pollution on brain health, in particular the development and progression of neurodegenerative diseases such as Alzheimer's disease (AD). We conducted a systematic review to evaluate the effects of long-term (months to years) exposure to outdoor air pollutants on the development and progression of AD using neuroimaging data.

Biomarkers.

Background: Using digital technologies to detect the early signs of dementia-causing diseases could improve the timely detection of these diseases. To support this approach, we explored users' perspectives on the acceptability of using a variety of digital technologies.

Method: A sub-group of participants from Boston University's Alzheimer's Disease Research Centre were recruited.

Technology and Dementia Preconference.

Background: With global dementia prevalence estimated to reach 139 million by 2050,(1) early detection of dementia-causing diseases is crucial for promoting preventative interventions. Wearable technologies have the potential to detect early signs; however, they need to be acceptable amongst users. We explored user's perspectives on the acceptability of wearable devices.